| Literature DB >> 30991064 |
Jing Yi1, Rong Bai1, Yue An2, Tian-Tian Liu2, Jia-Hao Liang2, Xiang-Ge Tian2, Xiao-Kui Huo2, Lei Feng2, Jing Ning2, Cheng-Peng Sun3, Xiao-Chi Ma2, Hou-Li Zhang4.
Abstract
As a part of our searching for natural human carboxylesterase 2 (human CES 2) inhibitors from traditional Chinese medicine, we found that the extract of Alisma orientale significantly inhibited human CES 2 in vitro. The investigation on A. orientale led to the isolation of a new protostane-type triterpenoid alismanin I (1). Its structure was determined according to HRESIMS, 1D and 2D NMR spectra. Alismanin I (1) displayed significantly inhibitory activity against human CES 2 with IC50 value of 1.31 ± 0.09 μM assayed by human CES 2-mediated DDAB hydrolysis. According to its inhibition kinetic result, compound 1 was a noncompetitive type inhibitor, and its Ki was 3.65 μM. Its inhibitory effect was confirmed in living cell level through a visual manner. The potential interaction mechanism of compound 1 with human CES 2 was also analyzed by circular dichroism (CD) spectrum and molecular docking.Entities:
Keywords: Docking; Human carboxylesterase 2; Triterpenoid
Year: 2019 PMID: 30991064 DOI: 10.1016/j.ijbiomac.2019.04.099
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953